Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.

Publication ,  Journal Article
Balducci, L; Lyman, GH
Published in: J Clin Oncol
March 1, 2001

Duke Scholars

Published In

J Clin Oncol

DOI

ISSN

0732-183X

Publication Date

March 1, 2001

Volume

19

Issue

5

Start / End Page

1583 / 1585

Location

United States

Related Subject Headings

  • Vincristine
  • Risk Factors
  • Prednisone
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Neutropenia
  • Infections
  • Humans
  • Granulocyte Colony-Stimulating Factor
  • Doxorubicin
 

Citation

APA
Chicago
ICMJE
MLA
NLM

Published In

J Clin Oncol

DOI

ISSN

0732-183X

Publication Date

March 1, 2001

Volume

19

Issue

5

Start / End Page

1583 / 1585

Location

United States

Related Subject Headings

  • Vincristine
  • Risk Factors
  • Prednisone
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Neutropenia
  • Infections
  • Humans
  • Granulocyte Colony-Stimulating Factor
  • Doxorubicin